openPR Logo
Press release

Immuno IVD Market 2019: Latest Innovations By Roche, Siemens Healthineers, Danaher Corporation, Abbott, Thermo Fisher Scientific, Johnson & Johnson, BD, Bio-Rad Laboratories, Sysmex Corporation, bioMérieux, DiaSorin, Ortho Clinical Diagnostics And Others

05-07-2019 02:02 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Global Immuno IVD Market

Global Immuno IVD Market

Immuno IVD market report presents a definite solution to obtain market insights with which you can think about market place clearly and thereby take important decisions for growth of the business. This report gives an absolute background analysis of the industry which includes an assessment of the parental market. This report is generated with the combination of best industry insight, practical solutions, talent solutions and latest technology. The principal areas of market analysis such as market definition, market segmentation, competitive analysis and research methodology are studied very vigilantly and precisely throughout the report.

This Immuno IVD report is structured with the meticulous efforts of our innovative, enthusiastic, knowledgeable and experienced team of analysts, researchers, industry experts, and forecasters. Competitive analysis is the major feature of any market research report, and hence Immuno IVD report covers many points including strategic profiling of key players in the market, analyse core competencies of key players, and draw a competitive landscape for the In Vitro Diagnostics industry. This Immuno IVD market report carries out an evaluation of the growth rate and the market value of industry based on market dynamics and growth inducing factors.

Market Analysis: Global Immuno IVD Market

Global Immuno IVD Market is set to witness a stable CAGR in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year of 2017. Increasing chronic and infectious disease is driving the growth of this market.

Want to study a sample copy? Click here to request. https://databridgemarketresearch.com/request-a-sample/?dbmr=global-immuno-ivd-market

Key Market Competitors: Global Immuno IVD Market

F. Hoffmann-La Roche Ltd, Siemens Healthcare GmbH, Danaher, Abbott, Thermo Fisher Scientific Inc, Johnson & Johnson Services Inc., BD, Bio-Rad Laboratories Inc., Sysmex Corporation, bioMérieux SA, DiaSorin, Ortho Clinical Diagnostics, Agilent Technologies Inc., QIAGEN, Bayer AG, Hologic Inc., Cepheid, Diagnostica Stago S.A.S., Leica Biosystems Nussloch GmbH, Quidel Corporation, OraSure Technologies Inc., Beckman Coulter Inc., and ARKRAY Inc.

Key Developments in the Market: Global Immuno IVD Market

In November 2018, Roche announced the launch of their first automated in vitro diagnostic (IVD) immunohistochemistry (IHC) assay which is specially designed to detect the tropomyosin receptor kinase (TRK) proteins in cancer. This new VENTANA pan-TRK (EPR17341) Assay has special tool which us to understand the TRK protein expression in cancer.

In February 2016, Beckman Coulter Diagnostics announced the launch of their compact DxH500 hematology system, which is designed to deliver quick and accurate results with just a speck of blood. This device offer up to 60 sample per hour. The main aim is to help the small hospitals and clinics to get the same and accurate result with their fully automated device.

Table Of Content: Global Immuno IVD Market

Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Global Immuno IVD Market Landscape
Part 04: Global Immuno IVD Market Sizing
Part 05: Global Immuno IVD Market Segmentation By Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers And Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis

And More…..Get Detailed TOC | At https://databridgemarketresearch.com/toc/?dbmr=global-immuno-ivd-market

Market Drivers: Global Immuno IVD Market

Increasing chronical and infectious diseases is driving the growth of this market

Technological development and advancement is driving the market

Market Restraints: Global Immuno IVD Market

High price of the immunodiagnostic products is restraining the market growth

Strict government regulations are restraining the market growth.

Competitive Analysis: Global Immuno IVD Market

Global immuno IVD market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of immuno IVD market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Primary Respondents: Global Immuno IVD Market

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Find the comprehensive research report here with a single click. https://databridgemarketresearch.com/reports/global-immuno-ivd-market/

Segmentation: Global Immuno IVD Market

By Product Type
o Reagents, Instruments, Software & Services

By Immunodiagnostics Technique
o Enzyme-Linked Immunosorbent Assay
 Chemiluminescence Immunoassays
 Fluorescence Immunoassays
 Colorimetric Immunoassays
o Rapid Tests
o Enzyme-Linked ImmunoSpot Assays
o Radioimmunoassay
o Western Blot
o Hematology

By Application
o Infectious Disease, Cancer, Cardiac, Disease, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, Other Indications

By End- User
o Standalone Laboratory, Hospitals, Academic & Medical Schools, Point of Care Testing, Others

By Geography
o North America, South America, Europe, Asia-Pacific, Middle East & Africa

Customization of the Report: Global Immuno IVD Market

All segmentation provided above in this report is represented at country level

All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Customization of the Report: Global Immuno IVD market report can be customized to meet the client’s requirements. Please connect with us (sopan.gedam@databridgemarketresearch.com), we will ensure that you get a report that suits your needs.

Reasons to Purchase this Report: Global Immuno IVD Market

Current and future of global immuno IVD market outlook in the developed and emerging markets

The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

Regions/Countries that are expected to witness the fastest growth rates during the forecast period

The latest developments, market shares, and strategies that are employed by the major market players

Know More Business Opportunities In Global Immuno IVD Market. Speak To Our Analyst And Gain Crucial Industry Insights That Will Help Your Business Expand Request Analyst Call On https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-immuno-ivd-market

About Us:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Immuno IVD Market 2019: Latest Innovations By Roche, Siemens Healthineers, Danaher Corporation, Abbott, Thermo Fisher Scientific, Johnson & Johnson, BD, Bio-Rad Laboratories, Sysmex Corporation, bioMérieux, DiaSorin, Ortho Clinical Diagnostics And Others here

News-ID: 1729988 • Views:

More Releases from Data Bridge Market Research

Precision gearbox market grow at a CAGR of 9.1% in the forecast period of 2022 to 2029
Precision gearbox market grow at a CAGR of 9.1% in the forecast period of 2022 t …
Precision gearbox market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses the market to reach at an estimated value of USD 5.9 billion by 2029 and grow at a CAGR of 9.1% in the above-mentioned forecast period. Market Overview This precision gearbox market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market
Neuropathic Pain Market is expected to undergo a CAGR of 9.2% during the forecast period of 2024 to 2031
Neuropathic Pain Market is expected to undergo a CAGR of 9.2% during the forecas …
Data Bridge Market Research analyses that the global neuropathic pain market, which was USD 5.86 billion in 2023, is expected to reach USD 11.86 billion by 2031, and is expected to undergo a CAGR of 9.2% during the forecast period of 2024 to 2031. Market Overview Neuropathic pain is a type of chronic pain caused by damage or dysfunction of the nervous system. It often presents as burning, shooting, or electric shock-kind
Radiology market registering a CAGR of 6.20% during the forecast period of 2022-2029
Radiology market registering a CAGR of 6.20% during the forecast period of 2022- …
Radiology market was valued at USD 26.6 billion in 2021 and is expected to reach USD 43.04 billion by 2029, registering a CAGR of 6.20% during the forecast period of 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. Market Overview Radiology (also referred as diagnostic imaging) includes multiple tests are included in the process, which
Cervical Retractors Market Size, Share, Trends, Key Drivers, Growth and Opportunity Analysis
Cervical Retractors Market Size, Share, Trends, Key Drivers, Growth and Opportun …
Global Cervical Retractors Market report focuses on several essential parameters related to the market that includes but are not limited to a competitive landscape, brief segmentation and industrial infrastructure. This marketing report offers an in-depth overview of product specification, technology, product type and production analysis considering major factors such as revenue, cost, and gross margin. Cervical Retractors market is supposed to grow during the forecast period due to growing demand

All 5 Releases


More Releases for Immuno

Organic Dispersion To Drive The Immuno-Oncology Market
The immuno-oncology therapy has shown excellent results in various clinical trials and in patients being treated with immune-oncology therapy. Immuno-oncology therapies can leverage patients' immune system and re-program the same to attack cancer cells, providing a safe and effective alternative. There has been an increasing demand for immuno-oncology therapy as several traditional methods used in the treatment of cancer such as chemotherapy, radiation therapy, and surgery, etc. carry the risk
Immuno Oncology Assays Market Size, Immuno Oncology Assays Market Prediction, Im …
The Immuno Oncology Assays Market Report examines the Immuno Oncology Assays industry from a variety of angles, including market size, status, trends, and forecasts. It also gives a quick rundown of the top competitors and development opportunities in the market. The research contains a comprehensive study of the keyword market, split by companies, regions, types, and applications. The research goes into great detail on several aspects that have been studied as
Next Gen Immuno-Oncology Congress - 4th Annual MarketsandMarkets
In the past decade, many scientific breakthroughs have been achieved through research including success in recent years of cancer immunotherapy with monoclonal antibodies, cancer vaccines, adoptive cell therapy and immune-checkpoint therapy. Personalized immunotherapy with various combinations will be the next promising strategy for the future cancer treatment direction. Register as a Delegate at https://www.reportsnreports.com/events/4th-annual-marketsandmarkets-next-gen-immuno-oncology-congress/register o 30+ experts from academia and industry will be presenting their current work in Immuno-Oncology, Latest updates on
Cell Therapy to Transform Immuno Oncology Landscape
"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights: • Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026 • Cell Therapy Clinical Trial Insight by Indication, Company & Country • Global Cell Therapy Clinical Pipeline: 767 Cell Therapies • Globally Marketed Cell Therapies: 25 Cell Therapies • Maximum Number of Marketed Cell Therapies In USA: 15 Therapies • Price & Product Insight By Region/Country • Regional Analysis of the Cell Therapy Market Download
Less than 4 Weeks until Immuno-Therapy Experts Gather at the Immuno-Oncology Con …
There’s just under 4 weeks until SMi’s Immuno-Oncology Conference commences in London on the 26th and 27th September (www.immuno-oncology-conference.com/openpr). The event aims to propagate thought-provoking discussions about the future of Immuno-Oncology between industry leaders, and update delegates on current key areas for development, advancements in therapy and revisions of regulations. The study of immuno-oncology has been ever-present in recent news, with biomarkers in melanoma having been recently identified by Dana-Farber Cancer Institute
Immuno-Oncology Conference, London – agenda released
Immuno-Oncology is a fast-paced field with massive potential to deliver successful and durable cancer therapies. SMi's Immuno-Oncology Conference (26 – 27 September 2018, London, UK) will focus on a few key areas of the field with representation of the whole industry, under each area. These areas will be drawn together to look towards the future of Immuno-oncology and how the field can progress. Agenda - Valuable time is spent to